Aix-Marseille Université, IRD, AP-HM, MEPHI, IHU-Méditerranée-Infection, Marseille, France.
Pédiatrie spécialisée et médecine infantile, Hôpital de la Timone, AP-HM, Marseille, France.
J Clin Microbiol. 2019 Feb 27;57(3). doi: 10.1128/JCM.00675-18. Print 2019 Mar.
The aim of this article is to review the human repertoire of bacteria in urine already described by culture and metagenomic techniques and published in the literature. Our study led us to compare this repertoire with other available human repertoires. We followed automatic and manual bibliographical methods and found 562 bacterial species reported in the literature as part of the human urinary microbiota. Of the 562 species, 322 were described only by culture, 101 by both culture and metagenomics, and 139 only by metagenomics. A total of 352 species (62.6%) have been associated with at least one case report of human infection, of which 225 (40.0%) have been described as causative agents of urinary tract infection. The urinary tract bacterial repertoire contains 21.4% of the known prokaryotic diversity associated with human beings (464 species in common), and it shares 23.6% species with the human gut microbiota (350 species in common, 62.3% of the urine species). The urinary repertoire shares a significant difference in aerointolerant species compared with those of the gut microbiota (100/562 [17.8%] and 505/1,484 [34.0%], respectively; < 0.001; odds ratio [OR] = 9.0 [7.0 to 11.4]). Studies using high-throughput sequencing show a higher proportion of aerointolerant bacteria in urine (74/240 [30.8%]) than studies using culture techniques (40/423 [9.5%]). Most pathogenic bacteria are part of the commensal human urinary tract bacteria, and their pathogenicity may occur following any imbalance of this microbiota. The restoration of urinary tract health can occur following a fecal transplantation. The potential gut origin of the human bacterial microbiota has to be explored.
本文旨在综述文献中已通过培养和宏基因组技术描述的人类尿液中的细菌组成。我们的研究使我们能够将该组成与其他可用的人类组成进行比较。我们遵循自动和手动文献方法,发现文献中报道的 562 种细菌是人类尿微生物组的一部分。在 562 种细菌中,322 种仅通过培养描述,101 种通过培养和宏基因组学描述,139 种仅通过宏基因组学描述。共有 352 种(62.6%)与至少 1 例人类感染病例相关,其中 225 种(40.0%)被描述为尿路感染的病原体。尿路细菌组成包含与人类相关的已知原核生物多样性的 21.4%(464 种共有),与人类肠道微生物组共享 23.6%的物种(350 种共有,尿液物种的 62.3%)。与肠道微生物组相比,尿液组成在耐气性物种方面存在显著差异(100/562[17.8%]和 505/1,484[34.0%];<0.001;比值比[OR] = 9.0[7.0 至 11.4])。使用高通量测序的研究显示,尿液中耐气性细菌的比例较高(74/240[30.8%]),而使用培养技术的研究比例较低(40/423[9.5%])。大多数致病性细菌是共生人类尿路细菌的一部分,其致病性可能在该微生物组发生任何失衡时发生。尿路健康的恢复可以通过粪便移植来实现。需要探索人类细菌微生物组的潜在肠道来源。